Notice NOT-DA-20-048 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-047 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-049 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-040 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-016 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-20-031 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to establish an institutional program for mentored training in global cancer research. This program will support research training led by US-based cancer research-intensive institutions working in collaboration with institutions in low and middle-income countries (LMICs). These training programs will be built upon the US institutions pre-existing training infrastructure and research collaborations with LMICs and will leverage these resources to expand the global cancer research workforce both in the US and in LMICs. The overarching goal of this grant program is to build capacity to conduct innovative and collaborative global research projects that will contribute to the advancement of basic, clinical, translational, and population-based cancer research.

College or university in science and mathematics fields including bioinformatics, biostatistics, computational biology, toxicology, epidemiology, statistics,…
From Oak Ridge Associated Universities - Tue, 14 Apr 2020 13:40:04 GMT - View all Morgantown, WV jobs

Funding Opportunity PAR-20-169 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. BTRCs also make their technologies available to other investigators, train members of the research community in the use of the technologies, and disseminate the technologies broadly.

Funding Opportunity PAR-20-167 from the NIH Guide for Grants and Contracts. This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the scholar can be considered to remain as an investigator within the intramural program.

2 years work-related experience in molecular assays, nucleic acid sequencing and basic bioinformatic analysis. Manage the operations of a designated laboratory;
From University of Wyoming - Tue, 14 Apr 2020 02:15:24 GMT - View all Laramie, WY jobs

F. Hoffmann-La Roche AG: At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about tran Switzerland (CH)

Notice NOT-EB-20-009 from the NIH Guide for Grants and Contracts

Notice NOT-NR-20-004 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-021 from the NIH Guide for Grants and Contracts

Notice NOT-AA-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-AA-20-007 from the NIH Guide for Grants and Contracts

Notice NOT-AG-20-028 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-165 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology and manifestations of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among individuals with ME/CFS, and the common mechanisms influencing the multiple affected body systems in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of disease processes and provide evidence-based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers and/or characterize the pathophysiological response of organ systems in individuals with ME/CFS. Applicants are encouraged to propose novel and innovative research that will break new ground or extend previous discoveries toward new directions.

Funding Opportunity PAR-20-168 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology and manifestations of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among individuals with ME/CFS, and the common mechanisms influencing the multiple affected body systems in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of disease processes and provide evidence-based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers and/or characterize the pathophysiological response of organ systems in individuals with ME/CFS. The R21 Grant mechanism is intended to support innovative, high impact research projects. Such projects would either 1) generate pilot data to assess the feasibility of a novel avenue of investigation; 2) involve high risk experiments that could lead to a breakthrough in ME/CFS; 3) demonstrate the feasibility of new technologies that could have a major impact on ME/CFS research. Proposals submitted under this mechanism should be limited to those with the potential for truly ground-breaking impact.

Notice NOT-HD-20-013 from the NIH Guide for Grants and Contracts